Letters |

Fish Oil vs Olive Oil for Postoperative Atrial Fibrillation

John G. F. Cleland, MD, PhD; Anil Joseph, MBBS, MRCP; Pierpaolo Pellicori, MD
JAMA. 2013;309(9):871-872. doi:10.1001/jama.2013.670.
Text Size: A A A
Published online


To the Editor: We were distressed to read yet another randomized controlled trial comparing fish oil with olive oil supplements being interpreted as evidence that such supplements are ineffective.1 It may well be that fish oil is not more effective than olive oil but does that mean that neither is effective?

There is ample evidence that olive oil supplements have effects on the cardiovascular system.2 One of the first large neutral trials of cardiovascular prevention, the World Health Organization clofibrate trial, used olive oil capsules as a placebo.3 Could this choice of placebo have influenced the result? A recent meta-analysis4 of randomized trials of fish oils suggested no overall benefit, but many of the trials used olive oil as the placebo. The analysts excluded Grupo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardio (GISSI)-Prevenzione because it was not a blinded study, even though the study showed a reduction in mortality. The meta-analysis also reported the placebo in the GISSI-Heart Failure5 study as nonoil although it was olive oil (Luigi Tavazzi, MD, written communication, December 14, 2012).


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview




March 6, 2013
Dariush Mozaffarian, MD, DrPH; Roberto Marchioli, MD
JAMA. 2013;309(9):871-872. doi:10.1001/jama.2013.673.
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.